273 results on '"Mowat, A P"'
Search Results
2. Mowat-Wilson syndrome: unraveling the complexities of diagnosis, treatment, and symptom management
- Author
-
Yalda Zhoulideh and Jamil Joolideh
- Subjects
Hirschsprung ,Mowat-Wilson syndrome ,MWS ,Rare disease ,ZEB2 ,Medicine (General) ,R5-920 ,Genetics ,QH426-470 - Abstract
Abstract Mowat-Wilson syndrome can be mentioned as one of the most severe and, at the same time, rare genetic abnormalities. The inheritance pattern of this disorder is an autosomal dominant pattern. In this disease, the ZEB2 gene becomes abnormal. The severity of the disease and associated signs and symptoms can vary widely but may include distinct facial features, developmental delay, intellectual disability, and Hirschsprung. MWS treatment may vary based on the specific symptoms that appear in each individual. This review will examine the gene involved in this disease, phenotype, clinical manifestations, ways of diagnosis, and treatment of this disease.
- Published
- 2024
- Full Text
- View/download PDF
3. Case Report: Novel compound heterozygous TPRKB variants cause Galloway-Mowat syndrome
- Author
-
Takuya Hiraide, Taiju Hayashi, Yusuke Ito, Rei Urushibata, Hiroshi Uchida, Ryoichi Kitagata, Hidetoshi Ishigaki, Tsutomu Ogata, Hirotomo Saitsu, and Tokiko Fukuda
- Subjects
TPRKB ,Galloway-Mowat syndrome ,exome sequencing ,KEOPS complex ,nephrotic proteinuria ,Pediatrics ,RJ1-570 - Abstract
BackgroundGalloway-Mowat syndrome (GAMOS) is a rare genetic disease characterized by early-onset nephrotic syndrome and microcephaly with central nervous system abnormalities. Pathogenic variants in genes encoding kinase, endopeptidase, and other proteins of small size (KEOPS) complex subunits cause GAMOS. The subunit TPRKB (TP53RK binding protein) has been reported in only two patients with GAMOS with homozygous missense variants.Clinical reportHerein, we described a three-year-old male with GAMOS. He exhibited developmental delay, developmental regression, microcephaly, distinctive facial features, skeletal abnormalities, and epilepsy. Brain magnetic resonance imaging revealed progressive brain atrophy, delayed myelination, T2-hypointense signals in the thalamus, and multiple intracranial abnormal signals on diffusion-weighted imaging. He presented with relapsing nephrotic proteinuria exacerbated by upper respiratory tract infections and progressive renal function decline. Exome sequencing identified compound heterozygous missense and frameshift variants in TPRKB: c.224dup, p.(Ser76IlefsTer3) and c.247C>T, p.(Leu83Phe).ConclusionsOur study supports that pathogenic TPRKB variants cause KEOPS complex-related GAMOS.
- Published
- 2024
- Full Text
- View/download PDF
4. Mowat–Wilson Syndrome: Case Report and Review of ZEB2 Gene Variant Types, Protein Defects and Molecular Interactions
- Author
-
Caroline St. Peter, Waheeda A. Hossain, Scott Lovell, Syed K. Rafi, and Merlin G. Butler
- Subjects
Mowat–Wilson syndrome (MWS) ,case report ,review ,ZEB2 gene variants ,ZEB2 protein domains and defects ,ZEB2 functional molecular interactions ,Biology (General) ,QH301-705.5 ,Chemistry ,QD1-999 - Abstract
Mowat–Wilson syndrome (MWS) is a rare genetic neurodevelopmental congenital disorder associated with various defects of the zinc finger E-box binding homeobox 2 (ZEB2) gene. The ZEB2 gene is autosomal dominant and encodes six protein domains including the SMAD-binding protein, which functions as a transcriptional corepressor involved in the conversion of neuroepithelial cells in early brain development and as a mediator of trophoblast differentiation. This review summarizes reported ZEB2 gene variants, their types, and frequencies among the 10 exons of ZEB2. Additionally, we summarized their corresponding encoded protein defects including the most common variant, c.2083 C>T in exon 8, which directly impacts the homeodomain (HD) protein domain. This single defect was found in 11% of the 298 reported patients with MWS. This review demonstrates that exon 8 encodes at least three of the six protein domains and accounts for 66% (198/298) of the variants identified. More than 90% of the defects were due to nonsense or frameshift changes. We show examples of protein modeling changes that occurred as a result of ZEB2 gene defects. We also report a novel pathogenic variant in exon 8 in a 5-year-old female proband with MWS. This review further explores other genes predicted to be interacting with the ZEB2 gene and their predicted gene–gene molecular interactions with protein binding effects on embryonic multi-system development such as craniofacial, spine, brain, kidney, cardiovascular, and hematopoiesis.
- Published
- 2024
- Full Text
- View/download PDF
5. A patient diagnosed with Galloway–Mowat syndrome presenting with a rod-cone functional anomaly with electronegative dark-adapted ERGs
- Author
-
Racine, Julie and Golden, Richard
- Published
- 2024
- Full Text
- View/download PDF
6. Generation of two iPSC lines from Mowat-Wilson syndrome patients carrying heterozygous ZEB2 mutations
- Author
-
Giulia Gorrieri, Serena Tamburro, Simona Baldassari, Sara Guerrisi, Federico Zara, Emilia Ricci, Duccio Maria Cordelli, Paolo Scudieri, and Ilaria Musante
- Subjects
Biology (General) ,QH301-705.5 - Abstract
ZEB2 is a protein-coding gene belonging to a very restricted family of transcription factors. ZEB2 acts mainly as a transcription repressor, is expressed in various tissues and its role is fundamental for the correct development of the nervous system. The best-known clinical picture associated with ZEB2 mutations is Mowat-Wilson syndrome, caused mostly by haploinsufficiency and characterized by possible multi-organ malformations, dysmorphic features, intellectual disability, and epilepsy. In this study we report the generation of IGGi004-A and IGGi005-A, iPSC clones from two patients carrying different heterozygous mutations in ZEB2, which can be used for disease modelling, pathophysiological studies and therapeutics testing.
- Published
- 2024
- Full Text
- View/download PDF
7. Congenital tracheal stenosis in Mowat-Wilson syndrome with nonsense mutation of ZEB2 gene
- Author
-
Lun-Chin Lin, Wan-Hsin Wen, and Peir-Taur Chen
- Subjects
Pediatrics ,RJ1-570 - Published
- 2024
- Full Text
- View/download PDF
8. Congenital tracheal stenosis in Mowat-Wilson syndrome with nonsense mutation of ZEB2 gene.
- Author
-
Lin, Lun-Chin, Wen, Wan-Hsin, and Chen, Peir-Taur
- Subjects
NONSENSE mutation ,TRACHEAL stenosis ,GENETIC mutation ,SYNDROMES - Published
- 2024
- Full Text
- View/download PDF
9. Generation of two iPSC lines from Mowat-Wilson syndrome patients carrying heterozygous ZEB2 mutations.
- Author
-
Gorrieri, Giulia, Tamburro, Serena, Baldassari, Simona, Guerrisi, Sara, Zara, Federico, Ricci, Emilia, Maria Cordelli, Duccio, Scudieri, Paolo, and Musante, Ilaria
- Abstract
ZEB2 is a protein-coding gene belonging to a very restricted family of transcription factors. ZEB2 acts mainly as a transcription repressor, is expressed in various tissues and its role is fundamental for the correct development of the nervous system. The best-known clinical picture associated with ZEB2 mutations is Mowat-Wilson syndrome, caused mostly by haploinsufficiency and characterized by possible multi-organ malformations, dysmorphic features, intellectual disability, and epilepsy. In this study we report the generation of IGGi004-A and IGGi005-A, iPSC clones from two patients carrying different heterozygous mutations in ZEB2 , which can be used for disease modelling, pathophysiological studies and therapeutics testing. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Unilateral progressive anterior iris adhesions in Mowat-Wilson syndrome: a new ocular finding.
- Author
-
Hernández-Marrero, Dayra, Junaidi, Radwan M., and Lyons, Christopher J.
- Subjects
IRIS (Eye) ,SYNDROMES ,ADHESION - Abstract
Ocular associations in Mowat-Wilson syndrome (MWS) are rare. Those involving the anterior segment are scarce in the literature. We describe a child with genetic confirmation of MWS that presented with acquired onset of unilateral anterior iris adhesions with no known trauma. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. Tissue Distribution and Toxicological Risk Assessment of Mercury and Other Elements in Northern Populations of Wolverine (Gulo gulo)
- Author
-
Chételat, John, Jung, Thomas S., Awan, Malik, Baryluk, Steven, Harrower, William, Kukka, Piia M., McClelland, Christine, Mowat, Garth, Pelletier, Nicolas, Rodford, Christine, and Stimmelmayr, Raphaela
- Published
- 2024
- Full Text
- View/download PDF
12. Within-field extrapolation away from a soil moisture probe using freely available satellite imagery and weather data
- Author
-
Bramley, R. G. V., Perry, E. M., Richetti, J., Colaço, A. F., Mowat, D. J., Ratcliff, C. E. M., and Lawes, R. A.
- Published
- 2024
- Full Text
- View/download PDF
13. Fear conditioning and fear generalization in children and adolescents with anxiety disorders
- Author
-
Reinhard, Julia, Mittermeier, Anna, Brandstetter, Lisa, Mowat, Kimberly, Slyschak, Anna, Reiter, Andrea M. F., Gamer, Matthias, and Romanos, Marcel
- Published
- 2024
- Full Text
- View/download PDF
14. The dynamin inhibitor, dynasore, prevents zoledronate-induced viability loss in human gingival fibroblasts by partially blocking zoledronate uptake and inhibiting endosomal acidification
- Author
-
Jacob KIRBY, Makayla STANDFEST, Jessica BINKLEY, Charles BARNES, Evan BROWN, Tyler CAIRNCROSS, Alex CARTWRIGHT, Danielle DADISMAN, Colten MOWAT, Daniel WILMOT, Theodore HOUSEMAN, Conner MURPHY, Caleb ENGELSMAN, Josh HALLER, and Daniel JONES
- Subjects
Bisphosphonate-associated osteonecrosis of the jaw ,Dynamins ,Endosomes ,Fibroblasts ,Zoledronic acid ,Dentistry ,RK1-715 - Abstract
Abstract Objective For treatment of medication-related osteonecrosis of the jaw, one proposed approach is the use of a topical agent to block entry of these medications in oral soft tissues. We tested the ability of phosphonoformic acid (PFA), an inhibitor of bisphosphonate entry through certain sodium-dependent phosphate contransporters (SLC20A1, 20A2, 34A1-3) as well as Dynasore, a macropinocytosis inhibitor, for their abilities to prevent zoledronate-induced (ZOL) death in human gingival fibroblasts (HGFs). Methodology MTT assay dose-response curves were performed to determine non-cytotoxic levels of both PFA and Dynasore. In the presence of 50 μM ZOL, optimized PFA and Dynasore doses were tested for their ability to restore HGF viability. To determine SLC expression in HGFs, total HGF RNA was subjected to quantitative real-time RT-PCR. Confocal fluorescence microscopy was employed to see if Dynasore inhibited macropinocytotic HGF entry of AF647-ZOL. Endosomal acidification in the presence of Dynasore was measured by live cell imaging utilizing LysoSensor Green DND-189. As a further test of Dynasore’s ability to interfere with ZOL-containing endosomal maturation, perinuclear localization of mature endosomes containing AF647-ZOL or TRITC-dextran as a control were assessed via confocal fluorescence microscopy with CellProfiler™ software analysis of the resulting photomicrographs. Results 0.5 mM PFA did not rescue HGFs from ZOL-induced viability loss at 72 hours while 10 and 30 μM geranylgeraniol did partially rescue. HGFs did not express the SLC transporters as compared to the expression in positive control tissues. 10 μM Dynasore completely prevented ZOL-induced viability loss. In the presence of Dynasore, AF647-ZOL and FITC-dextran co-localized in endosomes. Endosomal acidification was inhibited by Dynasore and perinuclear localization of both TRITC-dextran- and AF647-ZOL-containing endosomes was inhibited by 30 μM Dynasore. Conclusion Dynasore prevents ZOL-induced viability loss in HGFs by partially interfering with macropinocytosis and by inhibiting the endosomal maturation pathway thought to be needed for ZOL delivery to the cytoplasm.
- Published
- 2024
- Full Text
- View/download PDF
15. Study Findings from University of Kansas Medical Center Broaden Understanding of Molecular Science (Mowat-Wilson Syndrome: Case Report and Review of ZEB2 Gene Variant Types, Protein Defects and Molecular Interactions).
- Abstract
A recent study conducted by researchers at the University of Kansas Medical Center has provided new insights into Mowat-Wilson syndrome (MWS), a rare genetic neurodevelopmental disorder. The study focused on the zinc finger E-box binding homeobox 2 (ZEB2) gene, which is associated with MWS. The researchers identified various ZEB2 gene variants and their corresponding protein defects, with one variant in exon 8 being particularly common among patients with MWS. The study also explored the potential interactions between ZEB2 and other genes, highlighting their effects on embryonic development. For more information, the full study can be accessed through the International Journal of Molecular Sciences. [Extracted from the article]
- Published
- 2024
16. How to find a wolverine: Factors affecting detection at wolverine (Gulo gulo) bait stations in western Canada
- Author
-
Andrea Kortello, Doris Hausleitner, Garth Mowat, Mirjam Barrueto, Nicole Heim, Lisa Larson, Michael Lucid, and Anthony Clevenger
- Subjects
bait station ,capture–recapture ,detection ,genotyping success ,Gulo gulo ,inventory ,Ecology ,QH540-549.5 - Abstract
Abstract High individual detection success enables precise estimates of density and the ability to monitor trends in abundance for wolverine and other low‐density species, information that is critical for the implementation and assessment of conservation measures. We evaluated a dataset that included six different wolverine capture–recapture studies over a large gradient in wolverine (Gulo gulo) density to provide recommendations for increasing detection. We examined factors related to bait station components, habitat, and seasonal timing. Accounting for variation in wolverine density and trap duration, our results suggest that bait stations setups having a run pole, frame, and camera to photograph unique ventral color patterns, in addition to hair snag devices, identify more individual wolverine than those without. The presence of snow is a habitat feature that also increases individual detection. Female detection rates were lower than male detection rates at the onset of the reproductive denning season in late February and early March compared with January and early February. We found latency to detection was independent of wolverine density, but greater in areas with human influence. Relatively high rates of genotyping success (55%) were predicted by even a single guard hair left at bait stations, while underfur required ~15 hairs for similar success. Longer sampling intervals reduced genotyping success in spring, more so for underfur than guard hair. Hair samples acquired from barbwire were of higher quality than those from either alligator clips or gun brushes. To improve individual detection for wolverine inventory and monitoring, we recommend deploying run pole setups in areas with low human disturbance that will retain snow into late spring. Extending the winter trapping effort into April and May could increase the chances of detecting denning females. Latency to detection suggests that traps should be active for more than a month, especially in human‐influenced areas, but genotyping success suggests that traps should also be cleared of hair samples at smaller intervals of a month or less, during late winter/spring.
- Published
- 2024
- Full Text
- View/download PDF
17. A multitiered analysis platform for genome sequencing: Design and initial findings of the Australian Genomics Cardiovascular Disorders Flagship
- Author
-
Rachel Austin, Jaye S. Brown, Sarah Casauria, Evanthia O. Madelli, Tessa Mattiske, Tiffany Boughtwood, Alejandro Metke, Andrew Davis, Ari E. Horton, David Winlaw, Debjani Das, Magdalena Soka, Eleni Giannoulatou, Emma M. Rath, Eric Haan, Gillian M. Blue, Jitendra Vohra, John J. Atherton, Karin van Spaendonck-Zwarts, Kathy Cox, Leslie Burnett, Mathew Wallis, Matilda Haas, Michael C.J. Quinn, Nicholas Pachter, Nicola K. Poplawski, Zornitza Stark, Richard D. Bagnall, Robert G. Weintraub, Sarah-Jane Pantaleo, Sebastian Lunke, Paul De Fazio, Tina Thompson, Paul James, Yuchen Chang, Diane Fatkin, Ivan Macciocca, Jodie Ingles, Sally L. Dunwoodie, Chris Semsarian, Julie McGaughran, Lesley Ades, Annabel Enriquez, Alison McLean, Renee Smyth, Dimithu Alankarage, James McNamara, Morgan almog, Vanessa Fear, Caroline Medi, Mohammad Al-Shinnag, Miriam Fine, Raymond Sy, Keri Finlay, Di Milnes, Dotti Tang, Denisse Garza, Michael Milward, Jessica Taylor, Ansley Morrish, Shelby Taylor, Chris Barnett, Laura Gongolidis, Jim Morwood, Michel Tchan, Belinda Gray, Helen Mountain, Simon Bodek, Cassie Greer, David Mowat, Jordan Thorpe, Kirsten Boggs, Chai-Ann Ng, Alison Trainer, Michael Bogwitz, Mathilda Haas, Natalie Nowak, Gunjan Trivedi, Bernadette Hanna, Noelia Nunez Martinez, Giulia Valente, Alessandra Bray, Richard Harvey, Monique Ohanian, Marie-Jo Brion, Janette Hayward, Sinead O’Sullivan, Jamie Vandenberg, Jaye Brown, Carmen Herrera, Angela Overkov, Kunal Verma, Rob Bryson Richardson, Adam Hill, Miranda Vidgen, Georgie Hollingsworth, Chirag Patel, Charlotte Burns, Georgina Hollway, Mark Perrin, Kathryn Waddel-Smith, Michelle Cao, Matthew Perry, Will Carr, Denise Howting, Andreas Pflaumer, Peta Phillips, Meredith Wilson, Heather Chalinor, Joanne Isbister, Thuan Phuong, Matilda Jackson, Rachel Pope-Couston, Lisa Worgan, Gavin Chapman, Linda Wornham, Theosodia Charitou, Sarah Jane-Pantaleo, Preeti Punni, Kathy Wu, Belinda Chong, Renee Johnson, Laura Yeates, Felicity Collins, Andrew Kelly, Michael Quinn, Dominica Zentner, Gemma Correnti, Sarah King-Smith, Sulekha Rajagopalan, Edwin Kirk, Hariharan Raju, Fiona Cunningham, Sarah Kummerfeld, Timo Lassman, Matthew Regan, Jason Davis, Jonathon Lipton, Jonathan Rogers, Mark Ryan, Sarah Sandaradura, Michelle de Silva, Paul MacIntyre, Nicole Schonrock, Nicola Den Elzen, Paul Scuffham, Sophie Devery, Amali Mallawaarachchi, Julia Dobbins, Julia Mansour, Isabella Sherburn, Ellenore Martin, Mary-Clare Sherlock, Nathan Dwyer, Jacob Mathew, Emma Singer, Stefanie Elbracht-Leong, Carla Smerdon, David Elliott, and Janine Smith
- Subjects
Australian Genomics ,Cardiovascular genetic disorders ,Genome sequencing ,Specialized multidisciplinary care ,Genetics ,QH426-470 ,Medicine - Abstract
Purpose: The Australian Genomics Cardiovascular Disorders Flagship was a national multidisciplinary collaboration. It aimed to investigate the feasibility of genome sequencing (GS) and functional genomics to resolve variants of uncertain significance (VUS) in the clinical management of patients and families with cardiomyopathies, primary arrhythmias, and congenital heart disease (CHD). Methods: Between April 2019 and December 2021, 600 probands meeting cardiovascular disorder criteria from 17 cardiology and genetics clinics across Australia were enrolled in the Flagship and underwent GS. The Flagship adopted a tiered approach to GS analysis. Tier 1 analysis assessed genes with established clinical validity for each cardiovascular condition. Tier 2 analysis assessed lesser-evidenced research-based genes. Tier 3 analysis assessed the functional impact of VUS that remained after tier 1 and tier 2 analysis. Results: Overall, a pathogenic or likely pathogenic variant was identified in 41% of participants with a cardiomyopathy, 40% with an arrhythmia syndrome, and 15% with a familial CHD/CHD+Extra Cardiac Anomalies. A VUS outcome ranged from 13% for arrhythmias to 34% for CHD/CHD+Extra Cardiac Anomalies participants. Tier 2 research analysis identified a likely pathogenic/pathogenic variant for a further 15 participants and a VUS for an additional 15 participants. Conclusion: The Flagship successfully facilitated a model of care that harnesses clinical GS and functional genomics for the resolution of VUS in the clinical setting. This valuable data set can be used to inform clinical practice and facilitate research into the future.
- Published
- 2024
- Full Text
- View/download PDF
18. Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trial
- Author
-
Han, Baohui, Feinstein, Trevor, Shi, Yuankai, Chen, Gongyan, Yao, Yu, Hu, Chunhong, Shi, Jianhua, Feng, Jifeng, Wu, Huijuan, Cheng, Ying, Guo, Qi-sen, Jie, Zhijun, Ye, Feng, Zhang, Yiping, Liu, Zhihua, Mao, Weidong, Zhang, Liangming, Lu, Junguo, Zhao, Jun, Bazhenova, Lyudmila, Ruiz, Jimmy, Kloecker, Goetz H, Sujith, Kalmadi R, Oliff, Ira A, Wong, Matthew, Liu, Bin, Wu, Yanping, Huang, Lan, Sun, Yan, Han, Baohui, Feinstein, Trevor, Shi, Yuankai, Cheng, Gongyan, Yao, Yu, Hu, Chunhong, Shi, Jianhua, Feng, Jifeng, Wu, Huijuan, Cheng, Ying, Guo, Qi-sen, Jie, Zhijun, Ye, Feng, Zhang, Yiping, Liu, Zhihua, Mao, Weidong, Zhang, Liangming, Lu, Junguo, Zhao, Jun, Bazhenova, Lyudmila, Ruiz, Jimmy, Kloecker, Goetz, Kalmadi, R Sujith, Oliff, Ira, Wong, Matthew, Liu, Bin, Wu, Yanping, Huang, Lan, Sun, Yan, Luo, Feng, Zhou, Jian-ying, Pan, Hongming, Wang, Huaqing, Liu, Chunling, Cao, Lejie, Huang, Chao Hui, Thara, Eddie, Li, Xiaoling, Jiang, Da, Mowat, Rex B, Hrom, John S, Nagrial, Adnan, Jain, Vikram, Karim, Nagla A, Shunyakov, Leonid V, Kiberu, Andrew, Jennens, Ross, Lloyd, Ken, Wang, Zhongkun, Du, Lihua, and Li, Helen
- Abstract
There is an unmet need for second-line and third-line treatments that are effective and tolerable for advanced or metastatic non-small-cell lung cancer (NSCLC) with no driver mutations.
- Published
- 2024
- Full Text
- View/download PDF
19. The executive director of the Hong Kong Tourism Board outlines what's new.
- Author
-
MOWAT, BOW
- Subjects
YOUNG adults ,COVID-19 pandemic ,CHINESE New Year ,CULTURAL districts ,WINE festivals ,MUSEUM studies - Abstract
The executive director of the Hong Kong Tourism Board, Dane Cheng, discusses the changes in Hong Kong tourism due to the global pandemic. He highlights the growth of new markets, such as Vietnam and India, and the increased accessibility of Hong Kong with the addition of a third runway at the airport. Cheng emphasizes the importance of curating the experience for visitors, showcasing Hong Kong as a place where East meets West. He also mentions the challenges of limited air capacity and the need to differentiate Hong Kong from other destinations in Asia. Despite these challenges, Hong Kong continues to host major events and attract business travelers. Cheng emphasizes the importance of reinventing and positioning Hong Kong as a hip and authentic destination. [Extracted from the article]
- Published
- 2024
20. Virgin Atlantic: Always challenging the market.
- Author
-
MOWAT, BOB
- Subjects
WIRELESS power transmission ,AIRCRAFT fuels ,POINT-of-sale systems ,CANADIAN history ,TICKET sales ,TICKETS - Abstract
Virgin Atlantic is known for its innovation and commitment to providing excellent service. The airline prides itself on having high customer satisfaction scores and attributes this to its dedicated and skilled crew. In March 2025, Virgin Atlantic will launch flights from Toronto to London Heathrow, offering passengers a new aircraft with innovative features such as Bluetooth connectivity and wireless charging. The airline also places a strong emphasis on sustainability and aims to have a fully sustainable fleet by 2026. Virgin Atlantic has partnerships with Delta Airlines, Air France, and WestJet, which allows for enhanced connectivity and a wider range of destinations for travelers. The airline sees potential in the Toronto-London route and believes it can provide a unique and appealing experience for both leisure and business travelers. [Extracted from the article]
- Published
- 2024
21. Bermuda reinforces its investment in the Canadian market.
- Author
-
MOWAT, BOB
- Subjects
COVID-19 pandemic ,BUSINESS partnerships ,TOUR brokers & operators ,LANDFALL ,CONSUMERS ,TRAVEL agents - Abstract
Bermuda is reinforcing its investment in the Canadian market, with the director of global PR & brand partnerships for the Bermuda Tourism Authority, Kiwan Anderson, emphasizing the personal connection visitors have with the destination. The Bermuda Tourism Authority aims to celebrate the time lost during COVID and the reunions with loved ones. Anderson highlighted the success of BermudAir, which offers service from Toronto and Halifax, and expressed excitement for the future, including a brand refresh. The tourism authority values the input of travel agents and tour operators in understanding the needs of their customers and aims to educate travelers about Bermuda's unique culture, heritage, and culinary offerings. [Extracted from the article]
- Published
- 2024
22. Children and young people's self-reported experiences of asthma and self-management nursing strategies: An integrative review.
- Author
-
Kemble, H., Foster, M., Blamires, J., and Mowat, R.
- Abstract
To explore children and young people's (CYP) (5–24 years of age) self-reported experiences of asthma self-management strategies (ASMS) with nursing involvement across various settings. Childhood asthma is an increasingly significant health issue, highlighting the importance of acquiring self-management skills to optimise future health outcomes. Registered nurses play a pivotal role in delivering appropriate, personalized self-management support. This integrative review searched four electronic databases: Cumulated Index to Nursing and Allied Health Literature via Elton B. Stephens Company, Medical Literature Analysis and Retrieval System Online (MEDLINE), Object, View and Interactive Design (OVID), and PubMed, that followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis flowchart. Included studies were critically appraised using the Joanna Briggs Institute critical appraisal tools. Braun and Clarks thematic analysis was used to generate themes, and sub-themes. Fifteen studies were included for review. Thematic analysis generated three themes being healthy literacy; health and wellbeing; and tools and working together. Asthma continues to have negative physical, psychological, and social implications among CYP. CYP are both willing and capable of engaging in ASMS and learning self-management skills, however, continue to have unmet self-management needs. Strategies must bolster health literacy, improve physical and psychological health, and harness interactive, youth-centric, and informative tools to facilitate communication and decrease the burden of self-management. Applications pose a promising avenue for self-management support. This age group remains under-explored and future research should enable meaningful engagement with CYP to better understand their perspectives and improve strategy success. • Asthma continues to have negative physical, psychological, and social implications among young people. • Young people are willing and capable of engaging in asthma self management strategies and learning self-management skills. • Young people continue to have unmet asthma self-management (ASM) needs. • Strategies must bolster health literacy and harness tools to faciltate communication and decrease burden of ASM. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
23. Vacation homes provide agents with a new option for clients in Kissimmee.
- Author
-
MOWAT, BOB
- Published
- 2024
24. Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study
- Author
-
Chanchlani, Neil, Lin, Simeng, Bewshea, Claire, Hamilton, Benjamin, Thomas, Amanda, Smith, Rebecca, Roberts, Christopher, Bishara, Maria, Nice, Rachel, Lees, Charlie W, Sebastian, Shaji, Irving, Peter M, Russell, Richard K, McDonald, Timothy J, Goodhand, James R, Ahmad, Tariq, Kennedy, Nicholas A, Patel, Vinod, Mazhar, Zia, Saich, Rebecca, Colleypriest, Ben, Tham, Tony C, Iqbal, Tariq, Kaushik, Vishal, Murugesan, Senthil, Singh, Salil, Weaver, Sean, Preston, Cathryn, Butt, Assad, Smith, Melissa, Basude, Dharamveer, Beale, Amanda, Langlands, Sarah, Direkze, Natalie, Parkes, Miles, Torrente, Franco, De La Revella Negro, Juan, MacDonald, Chris Ewen, Evans, Stephen M, Gunasekera, Anton VJ, Thakur, Alka, Elphick, David, Shenoy, Achuth, Nwokolo, Chuka U, Dhar, Anjan, Cole, Andrew T, Agrawal, Anurag, Bridger, Stephen, Doherty, Julie, Cooper, Sheldon C, de Silva, Shanika, Mowat, Craig, Mayhead, Phillip, Lees, Charlie, Jones, Gareth, Ahmad, Tariq, Hart, James W, Kennedy, Nicholas A, Goodhand, James R, Lin, Simeng, Chanchlani, Neil, Nice, Rachel, McDonald, Timothy J, Bewshea, Claire, Al-Nuaimi, Yusur, Richards, Ellen, Haigh, Richard, Greenish, Huw, Heath, Harry, Gaya, Daniel R, Russell, Richard K, Gervais, Lisa, Dunckley, Paul, Mahmood, Tariq, Banim, Paul JR, Sonwalkar, Sunil, Ghosh, Deb, Phillips, Rosemary H, Azaz, Amer, Sebastian, Shaji, Shenderey, Richard, Armstrong, Lawrence, Bell, Claire, Hariraj, Radhakrishnan, Matthews, Helen, Jafferbhoy, Hasnain, Selinger, Christian P, Zamvar, Veena, De Caestecker, John S, Willmott, Anne, Miller, Richard, Babu, Palani Sathish, Tzivinikos, Christos, Bloom, Stuart L, Chung-Faye, Guy, Croft, Nicholas M, Fell, John ME, Harbord, Marcus, Hart, Ailsa, Hope, Ben, Irving, Peter M, Lindsay, James O, Mawdsley, Joel E, McNair, Alistair, Monahan, Kevin J, Murray, Charles D, Orchard, Timothy, Paul, Thankam, Pollok, Richard, Shah, Neil, Bouri, Sonia, Johnson, Matt W, Modi, Anita, Kabiru, Kasamu Dawa, Baburajan, B K, Bhaduri, Bim, Fagbemi, Andrew Adebayo, Levison, Scott, Limdi, Jimmy K, Watts, Gill, Foley, Stephen, Ramadas, Arvind, MacFaul, George, Mansfield, John, Grellier, Leonie, Morris, Mary-Anne, Tremelling, Mark, Hawkey, Chris, Kirkham, Sian, Charlton, Charles PJ, Rodrigues, Astor, Simmons, Alison, Lewis, Stephen J, Snook, Jonathon, Tighe, Mark, Goggin, Patrick M, De Silva, Aminda N, Lal, Simon, Smith, Mark S, Panter, Simon, Cummings, JR Fraser, Dharmisari, Suranga, Carter, Martyn, Watts, David, Mahmood, Zahid, McLain, Bruce, Sen, Sandip, Pigott, Anna J, Hobday, David, Wesley, Emma, Johnston, Richard, Edwards, Cathryn, Beckly, John, Vani, Deven, Ramakrishnan, Subramaniam, Chaudhary, Rakesh, Trudgill, Nigel J, Cooney, Rachel, Bell, Andy, Prasad, Neeraj, Gordon, John N, Brookes, Matthew J, Li, Andy, and Gore, Stephen
- Abstract
We sought to report the effectiveness of infliximab and adalimumab over the first 3 years of treatment and to define the factors that predict anti-TNF treatment failure and the strategies that prevent or mitigate loss of response.
- Published
- 2024
- Full Text
- View/download PDF
25. TRAVELSAVERS Canada: Bringing new solutions to market.
- Author
-
MOWAT, BOB
- Subjects
ARTIFICIAL intelligence ,FOOTBALL managers - Abstract
The article discusses the challenges faced by travel advisors in the current busy travel market. Despite the demand for their services, advisors struggle to find time to take breaks and learn new systems. TRAVELSAVERS Canada supports advisors by organizing Dine & Discover events, where they can refresh their education and learn about changes in supplier products and services. The article also mentions the resurgence of brick-and-mortar agencies, as some clients prefer meeting advisors in person. TRAVELSAVERS Canada is also exploring the use of artificial intelligence (AI) to support its members and save time. The company's KORE program aims to attract and train new travel advisors, with personalized mentorship and certification. [Extracted from the article]
- Published
- 2024
26. A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial
- Author
-
Noor, Nurulamin M, Lee, James C, Bond, Simon, Dowling, Francis, Brezina, Biljana, Patel, Kamal V, Ahmad, Tariq, Banim, Paul J, Berrill, James W, Cooney, Rachel, De La Revilla Negro, Juan, de Silva, Shanika, Din, Shahida, Durai, Dharmaraj, Gordon, John N, Irving, Peter M, Johnson, Matthew, Kent, Alexandra J, Kok, Klaartje B, Moran, Gordon W, Mowat, Craig, Patel, Pritash, Probert, Chris S, Raine, Tim, Saich, Rebecca, Seward, Abigail, Sharpstone, Dan, Smith, Melissa A, Subramanian, Sreedhar, Upponi, Sara S, Wiles, Alan, Williams, Horace R T, van den Brink, Gijs R, Vermeire, Séverine, Jairath, Vipul, D'Haens, Geert R, McKinney, Eoin F, Lyons, Paul A, Lindsay, James O, Kennedy, Nicholas A, Smith, Kenneth G C, and Parkes, Miles
- Abstract
Management strategies and clinical outcomes vary substantially in patients newly diagnosed with Crohn's disease. We evaluated the use of a putative prognostic biomarker to guide therapy by assessing outcomes in patients randomised to either top-down (ie, early combined immunosuppression with infliximab and immunomodulator) or accelerated step-up (conventional) treatment strategies.
- Published
- 2024
- Full Text
- View/download PDF
27. Introducing ONVIGO: a brand-new host agency group on the travel scene.
- Author
-
MOWAT, BOB
- Subjects
TRAVEL agents ,TOURISM - Abstract
ONVIGO is a new Canadian-owned and operated host agency group in the travel industry. Backed by Voyzant, ONVIGO aims to provide personalized support and inclusivity to travel advisors, with a focus on rebuilding the industry's talent pool. They offer services such as barrier-free access to careers in travel, managing invoices and chasing commissions on behalf of agents, and access to cutting-edge technology. Benefits of joining ONVIGO include personalized support, inclusivity, and industry rebuilding. ONVIGO aims to redefine success in the travel industry and create a community committed to the success of travel advisors. [Extracted from the article]
- Published
- 2024
28. A look at what's new with Arts & Leisure.
- Author
-
MOWAT, BOB
- Subjects
LEISURE ,AUTOMOBILE leasing & renting ,TOURS ,DESTINATION weddings ,TRAVEL agents ,CORPORATE retreats - Abstract
Arts & Leisure recently concluded its annual North American sales mission with a gathering of travel advisors at Toronto's Four Seasons Hotel. The company, founded in 1993, distinguishes itself as a travel curator rather than a tour operator, emphasizing its commitment to creating personalized and unforgettable journeys for clients. Arts & Leisure has expanded its presence with the opening of a new office in Naples, Italy, and has also become a member of the International Gay & Lesbian Travel Association, demonstrating its commitment to inclusivity. The company offers curated journeys to over 60 countries, with a focus on Europe but also including destinations in the Caribbean, Mexico, Central and North America. Future plans include expanding to Africa, Australia & Oceania, Indian & Pacific Ocean, and South America. Arts & Leisure works exclusively with travel advisors to create customized FIT packages, luxury villas, private jets, luxury yacht rentals, and small luxury group tours. The company's mission is to create the perfect holiday experience for clients, ensuring they return home with unforgettable stories. [Extracted from the article]
- Published
- 2024
29. Virtuoso tracks the trends at Canadian forum.
- Author
-
MOWAT, BOB
- Subjects
FOOTBALL managers ,CANADIANS ,TRAVEL agents ,FORUMS - Abstract
The Virtuoso Canadian Forum in Toronto brought together over 100 attendees from travel agencies specializing in luxury and experiential travel. The forum was marked by an optimistic outlook for the future of the industry, with Virtuoso Canada's general manager reporting a 22% sales growth in 2023 compared to the previous year. A survey conducted by Virtuoso also revealed that a majority of Canadian members and partners feel optimistic about future business. The top five emerging destinations for Canadian travelers were identified as Costa Rica, Japan, Portugal, Iceland, and Thailand. Canadians are now traveling more internationally than domestically. The motivations for Canadian travelers include relaxation, adventure, romantic getaways, cultural visits, celebrations, and health and wellness. Overall, the Canadian travel market is expected to experience growth in the coming years. [Extracted from the article]
- Published
- 2024
30. Flair seeks to make travel affordable for every Canadian.
- Author
-
MOWAT, BOB
- Subjects
WASTE products as fuel ,WAGES ,CANADIANS ,TRAVEL costs - Abstract
Flair Airlines' CEO, Stephen Jones, discussed the airline's performance in 2023, highlighting its affordability and sustainability efforts. Jones emphasized that Flair has consistently offered lower prices compared to larger airlines, resulting in significant savings for Canadian travelers. He also mentioned that Flair has achieved high performance metrics, including a 98.2% completion rate and 68.8% on-time arrivals in 2023. Additionally, Jones highlighted Flair's commitment to sustainability, with the airline having the lowest emissions per passenger mile flown in North America. Flair has also invested in communities, creating jobs and contributing to the economy. Looking ahead, Flair plans to continue expanding its network and offering affordable travel options for all Canadians. [Extracted from the article]
- Published
- 2024
31. Elevating the Power of Independents.
- Author
-
MOWAT, BOB
- Subjects
BUSINESSPEOPLE ,GENERATIVE artificial intelligence ,RESERVATION systems ,CRUISE industry ,BRAND name products - Abstract
Flight Centre Travel Group's Independent Division has rebranded its nine independent brands globally under the name Envoyage. The rebranding aims to create a unified global brand and provide independent travel advisors with an elevated brand that represents their expertise. Envoyage offers access to a diverse ecosystem of products, tools, and technologies, allowing advisors to tailor their offerings to their clients' needs. The launch of Envoyage has been well-received by advisors and agencies, and the company plans to expand its presence in Canada, the USA, and the UK. Additionally, Envoyage plans to develop new apps and technologies, including artificial intelligence tools, to enhance the advisor and client experience. [Extracted from the article]
- Published
- 2024
32. TRAVELSAVERS Canada: Leading with service first.
- Author
-
MOWAT, BOB
- Subjects
COVID-19 pandemic - Abstract
According to the article, TRAVELSAVERS Canada has seen stronger bookings in 2023 compared to 2024, with most package types experiencing single-digit growth. However, the cruise sector has rebounded better in 2024 than in 2023, as people are being more selective about their itineraries and booking in advance. The ITC side has seen a shift, with people going on one trip in 2024 compared to two trips in 2023, and being more budget-conscious. The economy, mortgage renewals, and unchanged prices by ITC operators are cited as factors influencing these trends. TRAVELSAVERS Canada is focusing on supporting its members and attracting new recruits through its KORE product and social media campaigns. The organization aims to provide excellent service and help members build their businesses. [Extracted from the article]
- Published
- 2024
33. The renaissance of oral tolerance: merging tradition and new insights
- Author
-
Cerovic, Vuk, Pabst, Oliver, and Mowat, Allan McI
- Abstract
Oral tolerance is the process by which feeding of soluble proteins induces antigen-specific systemic immune unresponsiveness. Oral tolerance is thought to have a central role in suppressing immune responses to ‘harmless’ food antigens, and its failure can lead to development of pathologies such as food allergies or coeliac disease. However, on the basis of long-standing experimental observations, the relevance of oral tolerance in human health has achieved new prominence recently following the discovery that oral administration of peanut proteins prevents the development of peanut allergy in at-risk human infants. In this Review, we summarize the new mechanistic insights into three key processes necessary for the induction of tolerance to oral antigens: antigen uptake and transport across the small intestinal epithelial barrier to the underlying immune cells; the processing, transport and presentation of fed antigen by different populations of antigen-presenting cells; and the development of immunosuppressive T cell populations that mediate antigen-specific tolerance. In addition, we consider how related but distinct processes maintain tolerance to bacterial antigens in the large intestine. Finally, we outline the molecular mechanisms and functional consequences of failure of oral tolerance and how these may be modulated to enhance clinical outcomes and prevent disease.
- Published
- 2024
- Full Text
- View/download PDF
34. Welcome to the Renaissance.
- Author
-
MOWAT, BOB
- Subjects
RENAISSANCE ,CUSTOMER relations ,DESTINATION weddings ,AIRLINE alliances - Abstract
The article discusses the positive outlook for travel advisors in the Travel Leaders Network. The president of Travel Leaders Group, John Lovell, states that consumers have made travel advisors their new best friends, leading to increased recruitment, retention, and partnerships with suppliers. Luxury travel, hotels, cruises, and group tours are all experiencing growth. The article also mentions the development of artificial intelligence tools, such as TobyAI, to support travel advisors in their work. Additionally, the group has launched Cruise Complete, a new cruise tool, and is working on a CRM Agnostic Customer API to enhance their engagement program. [Extracted from the article]
- Published
- 2024
35. JUST YOU: Gaining momentum as it creates a community for solo travellers.
- Author
-
MOWAT, BOB
- Subjects
PACKAGE tours ,WALKING tours ,GROUP tours ,SINGLE people ,SOCIAL enterprises ,GENERATION Z consumers ,WIDOWS ,CALL centers ,TRAVEL agents - Abstract
Just You, Solo Adventures Together, a UK-based company, is gaining momentum in Canada as it creates a community for solo travelers. The company focuses solely on solo travelers and guarantees each traveler their own room without paying a single supplement. Solo travel is growing in popularity, with over half of Canadians planning to travel solo more often or about the same in 2024. Just You offers a variety of escorted holiday tours on five continents, with plans to expand to six continents. The company is committed to changing lives through travel and works with the Planeterra Foundation to incorporate social enterprises into their programs. Travel advisors are the main distribution mechanism for Just You, and the company is working on offering agent rates and fam rates in the future. Just You has a call center in the UK and holiday advisors in Canada to provide support to Canadian agents. The response to Just You has been overwhelmingly positive, and the company is experiencing an increase in group requests. Overall, Just You is building momentum with new partnerships and a new brochure in the market. [Extracted from the article]
- Published
- 2024
36. THE NEXT CHAPTERS: Canadian Travel Press launches new, web-based video series featuring 15 new Voices of Travel.
- Author
-
MOWAT, BOB
- Subjects
VIDEOS ,HUMAN voice - Abstract
Canadian Travel Press has launched a new web-based video series called "Voices of Travel: The Next Chapters." This series features interviews with 15 industry professionals, including Brian Robertson, Denise Heffron, David Harris, Stephanie Bishop, Bruce Poon Tip, Flemming Friisdahl, Christine James, Maureen Barnes Smith, Joseph Adamo, Michael Merrithew, Rocky Racco, Dan Langevin, Wolf Paunic, Susan Webb, and David McClung. The interviews capture the passion, humor, and character of these individuals, and the series will be released on the Canadian Travel Press website and in their publication. This series aims to continue the tradition of sharing remarkable stories from the travel industry and will be ongoing beyond 2024. [Extracted from the article]
- Published
- 2024
37. Voices of Travel: KEEP LISTENING TO THE VOICES OF TRAVEL.
- Author
-
MOWAT, BOB
- Subjects
TOURISM ,STORYTELLING ,LISTENING ,CONVERSATION ,HUMAN voice - Abstract
The article titled "Voices of Travel: KEEP LISTENING TO THE VOICES OF TRAVEL" discusses a series by Canadian Travel Press called "Voices of Travel: The Next Chapters," which features interviews with various individuals in the Canadian travel industry. The series aims to provide an inside look at the experiences and passion of these individuals. The article emphasizes the importance of listening to these voices and acknowledges that people are what make the Canadian travel industry what it is. The series has concluded, but all episodes can still be watched on the Canadian Travel Press website. [Extracted from the article]
- Published
- 2024
38. Voices of Travel.
- Author
-
MOWAT, BOB
- Subjects
HUMAN voice - Abstract
The article titled "Voices of Travel" in Canadian Travel Press features an interview with Susan Webb, President of VoX International, who shares her journey into the travel industry. Webb initially planned to become a lawyer but decided to pursue a career in travel after a trip to Europe. She enrolled in Sheridan College's tourism and travel program and reflects on the changes in the industry over the years. The article highlights the fun and dedication of the industry in the past and provides a link to read Webb's full chapter. [Extracted from the article]
- Published
- 2024
39. IT’S ALL GOING TO BE “TECH DRIVEN” Dan Langevin writes the next chapter in Voices of Travel.
- Author
-
MOWAT, BOB
- Subjects
STORYTELLING ,HUMAN voice - Abstract
The article discusses the future of the travel industry, with a focus on technology and AI. The author interviews Dan Langevin, Chief Commercial Officer at Softvoyage, who has been in the industry his whole life. Langevin emphasizes the importance of embracing technology in order to stay relevant in the industry. He believes that technology will drive everything in the future and that AI will play a significant role. Langevin also reflects on his own passion for travel and how it has shaped his career. [Extracted from the article]
- Published
- 2024
40. Emergency presentation of colorectal cancer in older adults: A retrospective cohort analysis.
- Author
-
Nobes, Jennifer H., Baxter, Mark A., and Mowat, Craig
- Abstract
Adults aged 70 years and over account for almost 60% of colorectal cancer (CRC) diagnoses in the United Kingdom. Whilst emergency presentation of CRC is known to be associated with poorer outcomes across all ages, older adults are less likely to be treated with curative intent and have poorer overall survival (OS). We aimed to investigate whether presentation, management, or outcome differed in older (≥70 years) versus younger (<70 years) adults in our population. The electronic records of patients diagnosed with CRC within the period 2016 to 2019 in National Health Service (NHS) Tayside, Scotland were retrospectively analysed. Patients were grouped by age (<70 years and ≥70 years). Demographics were compared by Chi-squared or t -test, and Kaplan-Meier and Cox proportional hazard regression were used for survival analyses. In total, 1245 patients were diagnosed with CRC (median age 71 years, range 20–98). Of these, 215 patients (17.3%) presented emergently and were included in the analysis. Older adults accounted for 65.1% (n = 140) of emergency presentations. Older adults were less likely to present with classical symptoms of CRC (80.0% vs 90.7%, p = 0.04) and more likely to present via the medical assessment unit (46.4% vs 30.7%, p = 0.03). Additionally, older adults were less likely to receive a histological diagnosis of CRC (71.4% vs 97.3%, p < 0.001) or have complete staging investigations performed (78.6% vs 96.0%, p < 0.001). Fewer older adults underwent surgical management (55.0% vs 86.7%, p < 0.001) and fewer were treated with chemotherapy (14.3% vs 69.3%, p < 0.001). Whilst older adults had poorer median OS than those aged <70 years (12.0 vs 34.4 months, p < 0.001), multivariate Cox proportional hazards regression demonstrated that higher stage (stage III hazard ratio [HR] 2.7, 95% confidence interval [CI] 1.6–4.7, stage IV HR 16.7, 95% CI 9.7–28.8, incomplete HR 8.2, 95% CI 4.6–14.7) and not receiving chemotherapy (HR 2.6, 95% CI 1.7–4.0) were associated with poorer survival, whereas age and sex were not. Emergency presentation of colorectal cancer was more common in older adults. Older adults were more likely to present atypically, less likely to have completed staging, and had lower rates of intervention, which were associated with poorer survival outcome. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
41. Tu1118 HIGH DIMENSIONAL ANALYSIS OF 2500 PATIENT-REPORTED OUTCOMES AS A SCIENTIFIC PLATFORM TO STUDY IBD-ASSOCIATED FATIGUE.
- Author
-
Hall, Rebecca, Whelan, Robert J., Halligan, Molly J., Lau, Siu-Ying, Mowat, Craig, Campbell, Iona, Seenan, John Paul, MacDonald, Jonathan, Hodge, Mairi H., Chuah, Cher Shiong, and Ho, Gwo-Tzer
- Published
- 2024
- Full Text
- View/download PDF
42. Su1741 MULTIMODAL ANALYSIS IMPLICATES EXCESSIVE NECROPTOSIS IN SEVERELY ACTIVE GUT MUCOSAL INFLAMMATION AND IN BIOLOGIC NON-RESPONDERS TO ANTI-TNF/IL23 THERAPY IN IBD.
- Author
-
Whelan, Robert J., Cavanagh, Alexandra J., Webster, Josh, Scherl, Alexis, Lau, Siu-Ying, Hodge, Mairi H., Hall, Rebecca, Mowat, Craig, MacDonald, Jonathan, Seenan, John Paul, Chuah, Cher Shiong, Ramamoorthi, Nandhini, Vucic, Domagoj, Keir, Mary, and Ho, Gwo-Tzer
- Published
- 2024
- Full Text
- View/download PDF
43. The Boat Who Wouldn’t Float.
- Author
-
Grayson, Stan
- Abstract
"The Boat Who Wouldn't Float" by Farley Mowat is a memoir about the author's experience buying and sailing a sailboat in Newfoundland. The boat, named HAPPY ADVENTURE, had a personality of its own and often proved to be stubborn and dangerous. Mowat and his friend, Jack McClelland, purchased the boat with the intention of sailing it across the ocean, but their plans changed and they instead sailed to the nearby French islands of St. Pierre and Miquelon. The book, published in 1969, is a mix of adventure, humor, and Mowat's reflections on topics such as Canada's native peoples and wildlife. [Extracted from the article]
- Published
- 2024
44. Travel advisors getting 'Connected to Success' with TravelBrands.
- Author
-
MOWAT, BOB
- Subjects
CRUISE industry ,SUCCESS ,DISCRETIONARY income ,TRAVEL insurance ,MORTGAGE rates ,TRAVEL agents - Abstract
TravelBrands is focused on providing travel advisors with technology to help them succeed. The company has spent the last two years developing platforms for air consolidation and access to various travel services. Travel advisors have responded positively to these initiatives and are eager to learn more and receive training. TravelBrands emphasizes the importance of supporting travel advisors and providing excellent customer service. The company offers features such as 24/7 assistance and air seat protection. Technology has greatly improved the efficiency of booking travel, allowing advisors to make reservations quickly and easily. TravelBrands is also implementing artificial intelligence for data analytics and chatbots. Business has been exceptional for TravelBrands, with strong sales in the Caribbean, Mexico, and Europe. The company expects Europe to be a popular destination for Canadians in the coming months. The main challenges for the industry are factors beyond their control, such as economic conditions and consumer discretionary income. However, people's love for travel remains strong. [Extracted from the article]
- Published
- 2024
45. Virtuoso panel taps into 2024 travel trends.
- Author
-
MOWAT, BOB
- Subjects
SOCCER tournaments ,TRAVEL insurance ,OLYMPIC Games ,ACCIDENT insurance ,TRAVEL agents - Abstract
A panel of travel experts at the Virtuoso Canada Forum discussed travel trends for 2024. One trend identified was that clients of top-tier travel agencies in Canada are reconsidering their plans to travel to Europe during the summer due to high temperatures. Instead, they are considering traveling during the shoulder seasons (spring or fall) when temperatures are more comfortable. Other trends mentioned include the influence of rates on travel decisions and increased interest in destinations such as Asia, the South Pacific, Africa, the Caribbean, and Mexico City. The panel advised booking early, knowing your budget, and booking with a trusted supplier. [Extracted from the article]
- Published
- 2024
46. VOICES OF TRAVEL: THE NEXT CHAPTERS – BRUCE POON TIP’S EUREKA MOMENT.
- Author
-
MOWAT, BOB
- Subjects
HUMAN voice - Abstract
The article titled "VOICES OF TRAVEL: THE NEXT CHAPTERS – BRUCE POON TIP’S EUREKA MOMENT" discusses the founder of G Adventures, Bruce Poon Tip, and his journey in creating the company. Poon Tip explains that his idea for G Adventures came to him during a trip to Asia, where he refined his ideas and eventually quit his job to pursue his travel business. The article also mentions upcoming episodes in the "Voices of Travel: The Next Chapters" series, as well as previous episodes that are available for viewing. [Extracted from the article]
- Published
- 2024
47. DAVID HARRIS WRITES THE NEXT CHAPTER IN VOICES OF TRAVEL.
- Author
-
MOWAT, BOB
- Subjects
HUMAN voice - Abstract
The article titled "DAVID HARRIS WRITES THE NEXT CHAPTER IN VOICES OF TRAVEL" discusses the importance of consortiums in the travel industry. David Harris emphasizes that consortiums are crucial for agencies to have strength in their supplier agreements, access to technology, marketing opportunities, and training. The article also mentions that commission levels in the industry have changed over the past 40 years. The article provides links to watch episodes of the docuseries "Voices of Travel: The Next Chapters" featuring David Harris and Denise Heffron. [Extracted from the article]
- Published
- 2024
48. CELEBRATING MOMENTUM: Baxter Media launches the 24th annual Agents' Choice Readership Awards Survey.
- Author
-
MOWAT, BOB
- Subjects
READERSHIP surveys ,WOMEN'S shelters - Abstract
The article focuses on Baxter Media launching the 24th annual Agents' Choice Readership Awards Survey, celebrating the travel industry's momentum in 2024 after a remarkable recovery from the challenges of the past year. Topics include expanded categories in the survey, a new Momentum Award, and voting opportunities for travel advisors to recognize their favorite suppliers, with results to be announced at the Agents' Choice Awards Gala in June 2024.
- Published
- 2024
49. Microduplications of ARID1Aand ARID1Bcause a novel clinical and epigenetic distinct BAFopathy
- Author
-
van der Sluijs, Pleuntje J., Moutton, Sébastien, Dingemans, Alexander J.M., Weis, Denisa, Levy, Michael A., Boycott, Kym M., Arberas, Claudia, Baldassarri, Margherita, Beneteau, Claire, Brusco, Alfredo, Coutton, Charles, Dabir, Tabib, Dentici, Maria L., Devriendt, Koenraad, Faivre, Laurence, van Haelst, Mieke M., Jizi, Khadije, Kempers, Marlies J., Kerkhof, Jennifer, Kharbanda, Mira, Lachlan, Katherine, Marle, Nathalie, McConkey, Haley, Mencarelli, Maria A., Mowat, David., Niceta, Marcello, Nicolas, Claire, Novelli, Antonio, Orlando, Valeria, Pichon, Olivier, Rankin, Julia, Relator, Raissa., Ropers, Fabienne G., Rosenfeld, Jill A., Sachdev, Rani, Sandaradura, Sarah A., Shukarova-Angelovska, Elena, Steenbeek, Duco, Tartaglia, Marco, Tedder, Matthew A., Trajkova, Slavica, Winer, Norbert, Woods, Jeremy, de Vries, Bert B.A., Sadikovic, Bekim, Alders, Marielle, and Santen, Gijs W.E.
- Abstract
ARID1A/ARID1Bhaploinsufficiency leads to Coffin-Siris syndrome, duplications of ARID1Alead to a distinct clinical syndrome, whilst ARID1Bduplications have not yet been linked to a phenotype.
- Published
- 2024
- Full Text
- View/download PDF
50. Discovery of BAY-405: An Azaindole-Based MAP4K1 Inhibitor for the Enhancement of T-Cell Immunity against Cancer
- Author
-
Mowat, Jeffrey, Carretero, Rafael, Leder, Gabriele, Aiguabella Font, Nuria, Neuhaus, Roland, Berndt, Sandra, Günther, Judith, Friberg, Anders, Schäfer, Martina, Briem, Hans, Raschke, Marian, Miyatake Ondozabal, Hideki, Buchmann, Bernd, Boemer, Ulf, Kreft, Bertolt, Hartung, Ingo V., and Offringa, Rienk
- Abstract
Mitogen-activated protein kinase kinase kinase kinase 1 (MAP4K1) is a serine/threonine kinase that acts as an immune checkpoint downstream of T-cell receptor stimulation. MAP4K1 activity is enhanced by prostaglandin E2 (PGE2) and transforming growth factor beta (TGFβ), immune modulators commonly present in the tumor microenvironment. Therefore, its pharmacological inhibition is an attractive immuno-oncology concept for inducing therapeutic T-cell responses in cancer patients. Here, we describe the systematic optimization of azaindole-based lead compound 1, resulting in the discovery of potent and selective MAP4K1 inhibitor 38(BAY-405) that displays nanomolar potency in biochemical and cellular assays as well as in vivo exposure after oral dosing. BAY-405 enhances T-cell immunity and overcomes the suppressive effect of PGE2 and TGFβ. Treatment of tumor-bearing mice shows T-cell-dependent antitumor efficacy. MAP4K1 inhibition in conjunction with PD-L1 blockade results in a superior antitumor impact, illustrating the complementarity of the single agent treatments.
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.